As mentioned above, a number of proteomics studies have chosen specific brain regions (often the SN, in which significant neuronal loss occurs) to attempt to determine pathophysiological pathways in PD, and to delineate the biochemical pathways that link PD with GBA1 mutations. This evidence concerns the gene GBA1 and Parkinson disease.